Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AMR Roundtable: The Push And Pull Of Antimicrobial Development Incentives (Part 1)

Executive Summary

The Pink Sheet spoke with CEOs of antibiotic firm Zavante and antifungal specialist Amplyx as well as a BARDA official during a roundtable discussion at the recent BIO convention about what's needed to boost antimicrobial drug development, including "push" and "pull" incentives for drug makers.


Related Content

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch
Latest WHO Essential Medicines List: New Drugs And A New Way Of Tackling Antibiotic Resistance
Zavante Targets Resistant Urinary Infections With I.V. Version Of Existing Drug
Senate Dems Test Out 'Reasonable' Price Criteria With Antibiotic Incentive
Accelerating Antibiotics: Kevin Outterson And Joe Larsen Explain CARB-X
Antibiotic Development: Limited Population Pathway In US Removes Barrier
Antibiotic Development: ‘Wildcard Exclusivity’ Proposal Returns
Value-Based Reimbursement For Antibiotics Gets Skeptical Reception
With more cha-ching, will PDUFA V satisfy on the ba-bling?


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts